Clinical Trial Update: Varenicline on Reward Responses and Cognition in Adolescent Smokers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating varenicline's effects on reward responses and cognition in adolescent smokers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Yale University | Conditions: Tobacco Use Disorders | Phase 1 | Status: COMPLETED